Enochian Biosciences Inc.

NASDAQ: ENOB · Real-Time Price · USD
0.71
0.01 (1.43%)
At close: Aug 04, 2023, 9:58 PM

Enochian Biosciences Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-4.16M -4.55M -53.34M 42,826.9B -51.38M -4,270.1B -38,556.9B -4.06M -4.37M -7.19M -98.21M -4.04M -6.33M -7.5M -14.18M -3.05M -3.31M -2.86M
Interest Income
n/a n/a n/a 8.63K n/a n/a -8.63K n/a 3.01K 5.62K 99.15K 7.29K 8.49K 7.11K 4.37K 1.44K 3.07K 4.31K
Pretax Income
189.18K -7.25M -44.21M 44,213.1B -58.99M -4,529.1B -39,684B -4.33M -4.46M -7.7M -90.24M -6.2M -6.58M -10.41M -17.36M -4.03M -2.93M -2.52M
Net Income
189.18K -7.25M -44.21M 44,213.1B -58.99M -4,529.1B -39,296.9B -387.15B -4.55M -8.12M -175.52M -6.2M -6.58M -10.41M -17.36M -4.03M -2.93M -2.4M
Selling & General & Admin
4.22M 4.35M 5.3M 18,934.6B 7.65M 3,616.4B 15,318.2B 3.8M 4.01M 4.56M 3.16M 2.79M 4.16M 4.47M 2.08M 1.94M 1.94M 1.78M
Research & Development
94.07K 161.08K 390.19K 4,785.7B 1.09M 620.52B 4,165.2B 239.14K 325.96K 2.6M 1.77M 1.21M 2.14M 3.01M 12.07M 1.08M 1.33M 1.05M
Other Expenses
n/a 32.11K 47.65M n/a 42.64M 33.16B 19,073.5B 28.24K 28.84K 28.4K 28.33K n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
4.32M 4.55M 53.34M 23,720.3B 51.38M 4,270.1B 38,556.9B 4.06M 4.37M 7.19M 4.96M 4.04M 6.33M 7.5M 14.18M 3.05M 3.31M 2.86M
Interest Expense
-189K -98.89K -250K 855.33B -304K -274.98B -580.34B 264.86K 92.89K 95.58K 94.52K 95.21K 93.38K 89.74K 97.52K 96.35K 93.43K 92.31K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a n/a n/a 23,720.3B n/a 4,270.1B 38,556.9B 4.06M 4.37M 7.19M 4.96M 4.04M 6.33M 7.5M 14.18M 3.05M 3.31M 2.86M
Income Tax Expense
n/a n/a n/a 509.06K n/a n/a -387.15B 387.15B 89.88K 419.18K 85.28M n/a n/a 34.00 -475 -849 -1.16K -123K
Shares Outstanding (Basic)
162.34M 161.82M 156.57M 96.25M 109.25M 65.85M 56.27M 55.98M 55.51M 55.1M 52.53M 52.64M 52.32M 52.22M 49.69M 46.78M 46.66M 46.6M
Shares Outstanding (Diluted)
163.93M 161.82M 156.57M 96.25M 109.25M 65.85M 56.27M 55.98M 55.51M 55.1M 52.53M 52.64M 52.32M 52.22M 49.69M 46.78M 46.66M 46.6M
EPS (Basic)
0.00 -0.04 -0.28 459.37K -0.54 -0.07 -698.42K -6.92K -0.08 -0.15 -3.34 -0.12 -0.13 -0.2 -0.35 -0.09 -0.06 -0.05
EPS (Diluted)
0.00 -0.04 -0.28 459.37K -0.54 -0.07 -698.42K -6.92K -0.08 -0.15 -3.34 -0.12 -0.13 -0.2 -0.35 -0.09 -0.06 -0.05
EBITDA
-4.13M -4.51M -53.31M 44,921.8B -51.35M -4.24M -40,150.9B -4.04M -4.34M -7.16M -4.83M -4M -6.29M -10.47M -17.99M -4.1M -3M -2.58M
EBIT
-4.16M -4.55M -53.34M n/a -51.38M -4,804.1B -40,264.4B -4.06M -4.37M -7.6M -90.14M -6.11M -6.49M -10.32M -17.27M -3.94M -2.84M -2.43M
Depreciation & Amortization
31.98K 32.11K 32.38K -146.66B 30.3K 33.16B 113.5B 28.24K 28.84K 34.02K 93.38M 31.72K 31.8K 31.73K 31.49K 30.82K 30.76K 30.46K